CytoSorbents Corporation
(NASDAQ : CTSO)

( )
CTSO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.11%90.500.6%$484.45m
ABTAbbott Laboratories
-0.03%70.540.8%$474.95m
TMOThermo Fisher Scientific Inc.
-3.42%232.821.0%$441.54m
ISRGIntuitive Surgical, Inc.
-2.21%472.002.4%$431.26m
ALGNAlign Technology, Inc.
-4.04%196.176.3%$399.08m
BAXBaxter International Inc.
-2.23%65.031.7%$333.11m
BDXBecton, Dickinson and Company
-1.06%243.461.1%$323.42m
EWEdwards Lifesciences Corporation
-3.73%149.901.2%$264.79m
BSXBoston Scientific Corporation
-6.69%32.931.1%$254.87m
ABMDABIOMED, Inc.
-1.45%295.473.3%$243.17m
SYKStryker Corporation
-2.58%167.721.3%$241.45m
DXCMDexCom, Inc.
-12.19%121.318.5%$182.55m
ZBHZimmer Biomet Holdings, Inc.
-3.03%113.501.7%$145.35m
WATWaters Corporation
-0.89%197.803.5%$139.78m
XRAYDENTSPLY International Inc.
-0.75%36.923.1%$129.66m

Company Profile

CytoSorbents Corp. engages in the development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product, CytoSorb, is a extracorporeal cytokine filter and seeks to reduce cytokine storm that could otherwise cause massive inflammation, organ failure, and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.